The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Clinical Discovery Awards, 2006Alleviating late motor complications of Parkinson's disease by a continuous dopaminergic treatment with transdermal delivery of L-DOPA Pro-drug
NeuroDerm Ltd. is developing a novel delivery system of levodopa for the treatment of Parkinson's disease. Levodopa, a well-established medication for the treatment of Parkinson's disease (PD), is...
-
Clinical Discovery Awards, 2006The physiological mechanisms and treatment of fatigue in PD - a longitudinal study
Fatigue is a common problem in Parkinson's and many patients continue to be bothered by fatigue despite that they are taking medications to control their motor symptoms. Transcranial magnetic...
-
Clinical Discovery Awards, 2006Preventing falls and improving mobility in people with Parkinson's disease
Falls are common and disabling in people with Parkinson's disease, affecting up to 60% of those who live at home. This clinical research trial aims to minimize the number of falls and fall-related...
-
Clinical Discovery Awards, 2006Workplace Exposures and Biomarkers of Parkinsonism in Welders
The etiology of Parkinson's disease is unknown although previous research has implicated environmental factors in most cases. We have previously shown that welding, an occupation performed by over 500...
-
Clinical Discovery Awards, 2006Treating speech disorders in patients with Parkinson's disease using altered auditory feedback
Speech problems are common in patients with Parkinson's disease. At an early stage, patients may find it hard to project their voice. As the disease progresses, patients start to have difficulty...
-
Community Fast Track, 2005Nigrostriatal Dopaminergic Degeneration and Alpha-synuclein Aggregation in Mice with Reduced TrkB Signaling
Parkinson's disease (PD) is characterized by progressive loss of dopaminergic neurons and deposition of cytoplasmic protein aggregates termed Lewy bodies (LB) in a brain structure termed substantia...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.